Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

IMFINZI® Improves OS at Interim Analysis in CASPIAN Trial in Small Cell Lung Cancer

americanpharmaceuticalreviewJune 28, 2019

Tag: cancer , trial , IMFINZI®

PharmaSources Customer Service